Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Texas for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Texas only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Texas (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Andrew Mcclellan (NPI 1588935217)

Field	Value
Entity Type	Individual
Organization	Andrew Mcclellan
Address	9600 N Central Expy Ste 100
City	Dallas
State	TX
ZIP	75231
Taxonomy	Ophthalmology Physician
NPI Enumerated	January 26, 2012

Payer Source	Total Paid
Medicare	$4.5M
Medicaid	$0

Key Findings

This provider is an ophthalmology-focused practice that is heavily weighted toward intravitreal injectable therapies and retinal diagnostics: the top Medicare codes are J0178 (aflibercept injections), J2777 (faricimab injections), and J3490 (unclassified drugs), with substantial supporting volume in retinal imaging (92134) and isolated intravitreal injection procedure 67028. The mix of high-volume drug codes and retinal imaging suggests an operation centered on medical retina care (repeat injections and follow-up imaging) rather than primarily office-based general ophthalmology or high-volume surgical workflows.

Revenue concentration is extreme: the precomputed top-3 Medicare codes account for 82.2% of this provider's total Medicare revenue. Those top three line items break down as J0178 $2M revenue (44.7% of this provider's total Medicare revenue), J2777 $1.3M revenue (29.7% of this provider's total Medicare revenue), and J3490 $351.5K revenue (7.8% of this provider's total Medicare revenue), indicating most dollars are driven by a small number of high-cost injectable products.

Payer mix is effectively single-payer Medicare: lifetime Medicare revenue is $4.5M while Medicaid activity is absent (no Medicaid billing on file). This profile implies the provider’s commercial and Medicaid exposure is minimal or not captured in the dataset, so analyses of patient access or reimbursement sensitivity should be framed around Medicare-driven demand and pricing.

Competitive standing for the flagship product J0178 is well above peers: J0178 ranks #194 of 3204 providers nationally (94th percentile) and is described in the dataset as "notably above typical national volume for this code," indicating this clinician is a high-volume national participant for aflibercept administration. Similarly, 92134 (retinal diagnostic imaging) is reported as an "extreme outlier, far above typical national volume for this code," ranking #284 of 26868 providers nationally (99th percentile), which underscores unusually high imaging throughput relative to nearly all peers.

Other leading injection code J2777 is reported in the dataset as "typical, unremarkable volume for this code" despite a high percentile rank (J2777 ranks #127 of 2039 providers nationally, 94th percentile) and represents $1.3M (29.7% of this provider's total Medicare revenue). This suggests the provider’s faricimab billing is substantively material to revenue but is not flagged by the dataset as an anomalous practice pattern compared with the national distribution for that specific code.

Office evaluation and management services contribute only a small share of revenue relative to injectables and imaging: 92014 generated $83.1K (1.8% of this provider's total Medicare revenue) with 903 claims, and 99214 produced $41.9K (0.9% of this provider's total Medicare revenue) with 499 claims. Those figures point to a service model where procedure- and drug-based visits (injections and imaging) dominate revenue rather than high volumes of E/M visits.

Surgical and procedural retinal work appears limited in scale: example surgical codes such as 67042 ($17.7K, 0.4% of Medicare revenue for 21 claims) and 67036 ($9.6K, 0.2% of Medicare revenue for 14 claims) are present but represent a small fraction of total Medicare dollars. This pattern reinforces the characterization of a practice focused on recurring, office-based intravitreal therapy and diagnostics rather than inpatient or high-revenue surgical retina practice.

Provider tenure is established: NPI enumerated on 2012-01-26 (~14 years ago), indicating a long-standing Medicare participation history that supports interpretation of these high-volume patterns as sustained rather than newly emergent. Analysts should consider stability and historical presence when comparing peer movement or assessing capacity for growth in the drug-and-imaging service lines.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

28 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,930	$690	$2M
J2777	Injection, faricimab‑svoa, 0.1 mg	45,960	$30	$1.3M
J3490	Unclassified drugs	180	$2,000	$351.5K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	2,140	$100	$205.8K
J2781	Injection, pegcetacoplan, intravitreal, 1 mg	900	$120	$108.2K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	3,310	$30	$102.5K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	900	$90	$83.1K
J2778	Injection, ranibizumab, 0.1 mg	250	$180	$45.7K
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	500	$80	$41.9K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	240	$160	$37.6K

Showing 1–10 of 28

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 28 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Texas Distribution

Andrew Mcclellan — 1 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Texas

Full comparison — all codes billed, vs. state median

28 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	12	210	610	$690	$694.9K
J2777	11	140	7,470	$30	$479.2K
J2778	75	80	630	$180	$345.3K
Q5128	53	50	770	$220	$263.7K
J2781	19	50	720	$120	$131.9K
67028	26	290	510	$90	$73K
J3490	36	350	60	$480	$54.4K
67042	48	90	20	$1,150	$41.3K
J7312	16	40	200	$150	$40.8K
67113	22	30	20	$1,230	$29.4K

Showing 1–10 of 28

Related Providers

Other providers that share a Tax Identification Number (TIN) with Andrew Mcclellan, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Ashkan Abbey	TX	Ophthalmology Physician	$6.4M	$0
Lori Coors	TX	Ophthalmology Physician	$5.2M	$0
Ivan Castillo-salazar	TX	Ophthalmology Physician	$4.7M	$0
Wayne Solley	TX	Ophthalmology Physician	$4M	$0
Christopher Fuller	TX	Ophthalmology Physician	$3.6M	$0
Timothy Fuller	TX	Ophthalmology Physician	$3.5M	$0
Robert Wang	TX	Ophthalmology Physician	$3.5M	$0
Patrick Williams	TX	Ophthalmology Physician	$2.8M	$0
Nikisha Kothari	TX	Ophthalmology Physician	$2.4M	$0
Diana Laura	TX	Ophthalmology Physician	$2.3M	$0

Nearby Providers

Other providers in the same ZIP code as Andrew Mcclellan, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Dallas Independent School District	TX	Local Education Agency (LEA)	$0	$22.6M
North Star Home Health Care Inc	TX	Personal Care Attendant	$0	$10.8M
Ophthalmology Surgery Center Of Dallas, LLC	TX	Ambulatory Surgical Clinic/Center	$8.3M	$134.6K
Deborah Chong	TX	Ophthalmology Physician	$2.3M	$0
Morgan Click	TX	Family Nurse Practitioner	$2.1M	$0
Russell Lam	TX	Vascular Surgery Physician	$2M	$0
Center For Molecular Imaging Limited Partnership	TX	Radiology Clinic/Center	$2M	$0
Gary Fish	TX	Ophthalmology Physician	$2M	$0
Haskell Kirkpatrick	TX	Medical Oncology Physician	$1.8M	$0
Christopher Wright	TX	Rheumatology Physician	$1.4M	$0

Andrew Mcclellan — Billing Profile & Reimbursement Data

Sign up for Andrew Mcclellan — Billing Profile & Reimbursement Data policy alerts

Andrew Mcclellan — Billing Profile & Reimbursement Data

Sign up for Andrew Mcclellan — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References